Protective role of H₂S on acute renal damages in urinary-derived sepsis

References

• Levy MM, Artigas A, Phillips GS, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919–924.
   PubMed Web of Science ®Google Scholar
• Poukkanen M, Vaara ST, Pettila V, et al. Acute kidney injury in patients with severe sepsis in Finnish Intensive Care Units. Acta Anaesthesiol Scand. 2013;57(7):863–872.
   PubMed Web of Science ®Google Scholar
• Zhou J, Qian C, Zhao M, et al. Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China. PLoS One. 2014;9(9):e107181.
   PubMed Web of Science ®Google Scholar
• Wang R. Hydrogen sulfide: the third gasotransmitter in biology and medicine. Antioxidants Redox Signal. 2010;12(9):1061.
   PubMed Web of Science ®Google Scholar
• Wei X, Zhang B, Cheng L, et al. Hydrogen sulfide induces neuroprotection against experimental stroke in rats by down-regulation of AQP4 via activating PKC. Brain Res. 2015;1622:292–299.
   PubMed Web of Science ®Google Scholar
• Pan TT, Chen YQ, Bian JS. All in the timing: a comparison between the cardioprotection induced by HS preconditioning and post-infarction treatment. Eur J Pharmacol. 2009;616(1–3):160–165.
   PubMed Web of Science ®Google Scholar
• Li L, Li M, Li Y, et al. Exogenous H2S contributes to recovery of ischemic post-conditioning-induced cardioprotection by decrease of ROS level via down-regulation of NF-κB and JAK2-STAT3 pathways in the aging cardiomyocytes. Cell Biosci. 2016;6(1):26.
   PubMedGoogle Scholar
• Kasinath BS, Feliers D, Lee HJ. Hydrogen sulfide as a regulatory factor in kidney health and disease. Biochem Pharmacol. 2018;149:29–41.
   PubMed Web of Science ®Google Scholar
• Koning AM, Frenay AR, Leuvenink HG, et al. Hydrogen sulfide in renal physiology, disease and transplantation–the smell of renal protection. Nitric Oxide Biol Chem. 2015;46:37–49.
   PubMed Web of Science ®Google Scholar
• Xia M, Chen L, Muh RW, et al. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther.. 2009;329(3):1056–1062.
   PubMed Web of Science ®Google Scholar
• Beltowski J. Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. J Pharmacol Exp Ther. 2010;334(2):358–363.
   PubMed Web of Science ®Google Scholar
• Tripatara P, Patel NS, Brancaleone V, et al. Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study. Eur J Pharmacol. 2009;606(1–3):205–209.
   PubMed Web of Science ®Google Scholar
• Lin S, Visram F, Liu W, et al. GYY4137, a slow-releasing hydrogen sulfide donor, ameliorates renal damage associated with chronic obstructive uropathy. J Urol. 2016;196(6):1778–1787.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Olah G, Szczesny B, et al. AP39, a mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo. Shock (Augusta, GA). 2016;45(1):88–97.
   PubMed Web of Science ®Google Scholar
• Chen X, Wang Y, Luo H, et al. Ulinastatin reduces urinary sepsis related inflammation by upregulating IL10 and downregulating TNFalpha levels. Mol Med Rep. 2013;8(1):29–34.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu W, Wang Y, et al. Hydrogen sulfide reduces kidney injury due to urinary-derived sepsis by inhibiting NF-kappaB expression, decreasing TNF-alpha levels and increasing IL-10 levels. Exp Ther Med. 2014;8(2):464–470.
   PubMed Web of Science ®Google Scholar
• Qiu H, Chen X, Luo Z, et al. Inhibition of endogenous hydrogen sulfide production exacerbates the inflammatory response during urine-derived sepsis-induced kidney injury. Exp Ther Med. 2018;16(4):2851–2858.
   PubMed Web of Science ®Google Scholar
• Pathak E, MacMillan-Crow LA, Mayeux PR. Role of mitochondrial oxidants in an in vitro model of sepsis-induced renal injury. J Pharmacol Exp Ther. 2012;340(1):192–201.
   PubMed Web of Science ®Google Scholar
• Sacerdoti D, Pesce P, Di Pascoli M, et al. EETs and HO-1 cross-talk. Prostaglandins Other Lipid Mediat. 2016;125:65–79.
   PubMed Web of Science ®Google Scholar
• Zager RA, Johnson AC, Becker K. Plasma and urinary heme oxygenase-1 in AKI. JASN. 2012;23(6):1048–1057.
   Web of Science ®Google Scholar
• Foresti R, Clark JE, Green CJ, et al. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of superoxide and peroxynitrite anions. J Biol Chem. 1997;272(29):18411.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. 2016;315(8):801–810.
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Critical Care (London, England). 2008;12(2):R47.
   PubMed Web of Science ®Google Scholar
• Oppert M, Engel C, Brunkhorst FM, et al. Acute renal failure in patients with severe sepsis and septic shock–a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol Dial Transplant. 2007;23(3):904–909.
   PubMed Web of Science ®Google Scholar
• Mehta RL, Bouchard J, Soroko SB, et al. Sepsis as a cause and consequence of acute kidney injury: program to improve care in acute renal disease. Intensive Care Med. 2011;37(2):241–248.
   PubMed Web of Science ®Google Scholar
• Rajapakse S, Rodrigo C, Rajapakse A, et al. Renal replacement therapy in sepsis-induced acute renal failure. Saudi Journal of Kidney Diseases & Transplantation. 2009;20(4):553–559.
   PubMedGoogle Scholar
• Barbar SD, Clere-Jehl R, Bourredjem A, et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med. 2018;379(15):1431–1442.
   PubMed Web of Science ®Google Scholar
• Albanopoulos K, Alevizos L, Natoudi M, et al. C-reactive protein, white blood cells, and neutrophils as early predictors of postoperative complications in patients undergoing laparoscopic sleeve gastrectomy. Surg Endosc. 2013;27(3):864–871.
   PubMed Web of Science ®Google Scholar
• Kirkeboen KA, Strand OA. The role of nitric oxide in sepsis–an overview. Acta Anaesthesiol Scand. 1999;43(3):275–288.
   PubMed Web of Science ®Google Scholar
• Li WC, Zou ZJ, Zhou MG, et al. Effects of simvastatin on the expression of inducible NOS in acute lung injury in septic rats. Int J Clin Exp Pathol. 2015;8(11):15106–15111.
   PubMed Web of Science ®Google Scholar
• Prauchner CA. Oxidative stress in sepsis: pathophysiological implications justifying antioxidant co-therapy. Burns: J Int Soc Burn Injuries. 2017;43(3):471–485. PubMed PMID: 28034666; eng.
   PubMed Web of Science ®Google Scholar
• Quoilin C, Mouithys-Mickalad A, Lecart S, et al. Evidence of oxidative stress and mitochondrial respiratory chain dysfunction in an in vitro model of sepsis-induced kidney injury. Biochim Biophys Acta. 2014;1837(10):1790–1800.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Takeno M, Saito T, et al. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum. 2006;54(4):1132–1142.
   PubMedGoogle Scholar
• Wu CC, Lu KC, Chen JS, et al. HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects. Nephrol Dial Transplant. 2008;23(10):3082–3090. PubMed PMID: 18477570; eng.
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz J, Walczewska M, Olszanecki R, et al. Taurine haloamines and heme oxygenase-1 cooperate in the regulation of inflammation and attenuation of oxidative stress. Adv Exp Med Biol. 2009;643:439–450. [https://doi.org/19239176]
   PubMed Web of Science ®Google Scholar
• Ryter SW, Choi AM. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res J Lab Clin Med. 2016;167(1):7–34.
   Google Scholar
• Ayer A, Zarjou A, Agarwal A, et al. Heme oxygenases in cardiovascular health and disease. Physiol Rev. 2016;96(4):1449–1508.
   PubMed Web of Science ®Google Scholar
• Konrad FM, Knausberg U, Hone R, et al. Tissue heme oxygenase-1 exerts anti-inflammatory effects on LPS-induced pulmonary inflammation. Mucosal Immunol. 2016;9(1):98–111.
   PubMed Web of Science ®Google Scholar
• Kawashima A, Oda Y, Yachie A, et al. Heme oxygenase-1 deficiency: the first autopsy case. Human Pathol. 2002;33(1):125–130.
   PubMed Web of Science ®Google Scholar
• Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103(1):129–135.
   PubMed Web of Science ®Google Scholar
• Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Nat Acad Sci USA. 1997;94(20):10925.
   PubMed Web of Science ®Google Scholar
• Kamimoto M, Mizuno S, Matsumoto K, et al. Hepatocyte growth factor prevents multiple organ injuries in endotoxemic mice through a heme oxygenase-1-dependent mechanism. Biochem Biophys Res Commun. 2009;380(2):333–337.
   PubMed Web of Science ®Google Scholar
• Yokoyama T, Shimizu M, Ohta K, et al. Urinary heme oxygenase-1 as a sensitive indicator of tubulointerstitial inflammatory damage in various renal diseases. Am J Nephrol. 2011;33(5):414–420.
   PubMed Web of Science ®Google Scholar
• Yu JB, Zhou F, Yao SL, et al. Effect of heme oxygenase-1 on the kidney during septic shock in rats. Transl Res J Lab Clin Med. 2009;153(6):283–287.
   Google Scholar
• Nath KA. The role of renal research in demonstrating the protective properties of heme oxygenase-1. Kidney Int. 2013;84(1):3–6.
   PubMed Web of Science ®Google Scholar
• Yu J, Shi J, Wang D, et al. Heme oxygenase-1/carbon monoxide-regulated mitochondrial dynamic equilibrium contributes to the attenuation of endotoxin-induced acute lung injury in rats and in lipopolysaccharide-activated macrophages. Anesthesiology. 2016;125(6):1190–1201.
   PubMed Web of Science ®Google Scholar
• Bolisetty S, Zarjou A, Agarwal A. Heme oxygenase 1 as a therapeutic target in acute kidney injury. Am J Kidney Dis Off J Nat Kidney Found. 2017;69(4):531–545.
   PubMed Web of Science ®Google Scholar
• Yang R, Jia Q, Liu XF, et al. Effects of hydrogen sulfide on inducible nitric oxide synthase activity and expression of cardiomyocytes in diabetic rats. Mol Med Rep. 2017;16(4):5277–5284.
   PubMed Web of Science ®Google Scholar
• D'Araio E, Shaw N, Millward A, et al. Hydrogen sulfide induces heme oxygenase-1 in human kidney cells. Acta Diabetol. 2014;51(1):155–157.
   PubMed Web of Science ®Google Scholar
• Oh GS, Pae HO, Lee BS, et al. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Rad Biol Med. 2006;41(1):106–119.
   PubMed Web of Science ®Google Scholar
• Hua W, Chen Q, Gong F, et al. Cardioprotection of H2S by downregulating iNOS and upregulating HO-1 expression in mice with CVB3-induced myocarditis. Life Sci. 2013;93(24):949–954.
   PubMed Web of Science ®Google Scholar